Data / Form D filings / TiGenix NV
TiGenix NV: Form D filings
TiGenix NV, a biotechnology company in Leuven, Belgium, filed 2 Form D notices with the SEC between 2013 and 2018. The latest, on January 9, 2018, reports $25,902 sold of a $195,412 offering to 2 investors.
Find out what TiGenix NV does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ROMEINSE STRAAT 12 BOX 2, 3001, Leuven, Belgium, 3001
- Phone
- (321) 639-7937
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Belgium
- Revenue range
- $25,000,001 - $100,000,000
- Exemptions claimed
- Rule 506(b), Securities Act section 4(a)(5)
- SEC identifier (CIK)
- 1581987
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 9, 2018 | New notice | $195,412 | $25,902 | $169,510 | 2 | Nov 16, 2017 | sec.gov |
| Jul 24, 2013 | New notice | $8,540,220 | $8,540,220 | $0 | 25 | Jul 18, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Claudia D'Augusta | Executive Officer | |
| June Almenoff | Director | |
| Russell Greig | Director | |
| Eduardo Bravo Fernandez de Araoz | Executive Officer, Director | |
| Jean Stephenne | Director | |
| Marie Paule Richard | Executive Officer | |
| Willy Duron | Director | |
| Wilfried Dalemans | Executive Officer |
Every Form D from the week of Jan 8, 2018 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what TiGenix NV reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.